Charles E. Warren
From Wikipedia, the free encyclopedia
Charles E. Warren | |
|---|---|
 | |
| Born | September 17, 1962 Guildford, U.K. |
| Died | July 30, 2005 (aged 42) Calgary, Alberta, Canada |
| Alma mater | |
| Known for | Glycobiology |
| Scientific career | |
| Fields | Glycobiology |
| Institutions | New Hampshire University |
| Doctoral advisor | Raymond Dwek |
Charles E. Warren (September 17, 1962 – July 30, 2005)[1] was an assistant professor of biochemistry and molecular biology at the University of New Hampshire.
Warren was born on September 17, 1962, in Guildford, UK. He was son of Joan (Staples) Warren and the late Charles Peter Warren. He was educated at Oxford University, where he received his PhD in 1989 under the mentorship of Raymond Dwek, an eminent early leader in glycobiology. His thesis was entitled Glycosylation in Mice and Rats.[full citation needed]
Research
After graduation he helped establish the first commercially focused effort in glycotechnology: Oxford Glycosystems, Ltd.[2] He subsequently moved to Toronto, Canada, to broaden his interest in glycosyltransferase and spent his postdoctoral time with Dr. Harry Schachter at the Hospital for Sick Children in Toronto, and two years later across the street with Dr. Jim Dennis[3] at the Lunenfeld-Tanenbaum Research Institute. Charles Warren moved to the University of New Hampshire in 2002 as an assistant professor in the Department of Biochemistry and Molecular Biology.
He conducted research on the structure-function relationships of glycosylation. These specific efforts focused on evolution, animal development and human diseases.[4][5] He used C. elegans as his model organism.[6][7]
Awards
After only three years at the University of New Hampshire, he was nominated for a named professorship, the Class of 1944 Award. This university-wide award recognizes outstanding faculty members.[8]